- Home
- CISO vs COEP Comparison
CISO vs COEP Comparison
Compare CISO & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- COEP
- Stock Information
- Founded
- CISO 2015
- COEP 2017
- Country
- CISO United States
- COEP United States
- Employees
- CISO N/A
- COEP N/A
- Industry
- CISO Computer Software: Prepackaged Software
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CISO Technology
- COEP Health Care
- Exchange
- CISO Nasdaq
- COEP Nasdaq
- Market Cap
- CISO 31.4M
- COEP 27.4M
- IPO Year
- CISO N/A
- COEP N/A
- Fundamental
- Price
- CISO $1.01
- COEP $10.92
- Analyst Decision
- CISO
- COEP
- Analyst Count
- CISO 0
- COEP 0
- Target Price
- CISO N/A
- COEP N/A
- AVG Volume (30 Days)
- CISO 794.2K
- COEP 55.9K
- Earning Date
- CISO 08-13-2025
- COEP 08-15-2025
- Dividend Yield
- CISO N/A
- COEP N/A
- EPS Growth
- CISO N/A
- COEP N/A
- EPS
- CISO N/A
- COEP N/A
- Revenue
- CISO $29,887,603.00
- COEP $62,874.00
- Revenue This Year
- CISO N/A
- COEP N/A
- Revenue Next Year
- CISO N/A
- COEP N/A
- P/E Ratio
- CISO N/A
- COEP N/A
- Revenue Growth
- CISO N/A
- COEP N/A
- 52 Week Low
- CISO $0.26
- COEP $2.31
- 52 Week High
- CISO $3.84
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- CISO 43.38
- COEP 57.24
- Support Level
- CISO $1.03
- COEP $11.30
- Resistance Level
- CISO $1.15
- COEP $12.71
- Average True Range (ATR)
- CISO 0.08
- COEP 0.91
- MACD
- CISO -0.01
- COEP 0.09
- Stochastic Oscillator
- CISO 16.67
- COEP 47.27
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.